Publications by authors named "T Strunk"

Introduction: Compromised neonatal intensive care unit neonates are at risk of acquiring late-onset infections (late-onset sepsis [LOS]). Neonates born with congenital anomalies (CAs) could have an additional LOS risk.

Methods: Utilising the population-based Australian and New Zealand Neonatal Network data from 2007 to 2017, bacterial LOS rates were determined in very preterm (VPT, <32 week), moderately preterm (MPT, 32-36 weeks), and term (FT, 37-41 weeks) neonates with or without CA.

View Article and Find Full Text PDF

Background: Early-life antibiotic exposure is disproportionately high compared to the burden of culture-proven early-onset sepsis (CP-EOS). We assessed the contribution of culture-negative cases to the overall antibiotic exposure in the first postnatal week.

Methods: We conducted a retrospective analysis across eleven countries in Europe, North America, and Australia.

View Article and Find Full Text PDF
Article Synopsis
  • * The study examined how factors like scaffold layering, cross-linking time, and freeze-drying impact the stability and properties of these nanofibers, finding that cross-linking with formaldehyde vapor offers optimal stability.
  • * Results show that different cross-linking times alter mechanical properties without changing hydration, and the nanofibers have a higher susceptibility to enzyme degradation compared to planar forms, highlighting their potential in soft tissue applications.
View Article and Find Full Text PDF
Article Synopsis
  • There is a significant need for clinical trials that include infants, children, and adolescents to ensure evidence-based care; this communication discusses three different trial design strategies to address this issue.
  • The three strategies include sequential, parallel, and unified adult-pediatric Bayesian adaptive designs, which allow for better integration of pediatric populations into clinical research.
  • The unified design, exemplified by the SNAP trial, utilizes Bayesian hierarchical models to share data across age groups, enhancing accuracy in assessing treatment safety and efficacy for both children and adults.
View Article and Find Full Text PDF